Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butyl-bromide vs Ondansetron for IONV in C-section
NCT04785118Phase 4Completed
- Sponsor
- Assiut University
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 4 trial of hyoscine butylbromide in nausea ((none)), Vomiting, sponsored by Assiut University. Started Oct 2021; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT04785118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04785118.